PERINDOPRIL ERBUMINE 2 MG
PERINDOPRIL ERBUMINE : 2 MG · DIN 02481634 · SANIS HEALTH INC
Health Canada status: MARKETED
Overview
PERINDOPRIL ERBUMINE 2 MG contains PERINDOPRIL ERBUMINE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02481634, held by SANIS HEALTH INC, supplied as TABLET for ORAL administration. Nexara Health is a licensed Canadian wholesale distributor and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details
| DIN | 02481634 |
|---|---|
| Brand name | PERINDOPRIL ERBUMINE |
| Generic / active ingredient | PERINDOPRIL ERBUMINE : 2 MG |
| Manufacturer | SANIS HEALTH INC |
| Strength | 2 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09AA04 PERINDOPRIL |
| AHFS class | 24:32.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Original market date | 2019-03-18 00:00:00 |
Indications
Treatment of mild to moderate essential hypertension; mild to moderate congestive heart failure; reduction of cardiovascular risk in patients with stable coronary artery disease.
Dosage and administration
Hypertension: 4-8 mg daily. CHF: 2-4 mg daily. Stable CAD: 4-8 mg daily. Take once daily in the morning before a meal. Individualize for elderly and renal impairment.
Contraindications
Hypersensitivity; history of angioedema; pregnancy/nursing; galactose intolerance; combination with sacubitril/valsartan or aliskiren (in diabetics/renal impairment); bilateral renal artery stenosis.
Warnings and precautions
Serious Warning: Fetal injury/death in pregnancy. Risk of life-threatening head/neck angioedema, intestinal angioedema, and symptomatic hypotension. Caution in aortic stenosis.
Storage and handling
Not explicitly detailed in provided text (Section 11 referenced but content missing), though standard USP tablets typically store at 15-30°C.
Packaging
2 mg, 4 mg, 8 mg: HDPE containers of 100 and 500 tablets; blister packs of 30 tablets.
Alternatives in the same therapeutic class
Products sharing ATC code C09AA04 PERINDOPRIL. Marketed products are listed first. Substitution decisions rest with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Manufacturer | Strength | Health Canada status | DIN |
|---|---|---|---|---|
| AG-PERINDOPRIL ERBUMINE | ANGITA PHARMA INC. | 2 MG | MARKETED | DIN 02529491 |
| AG-PERINDOPRIL ERBUMINE | ANGITA PHARMA INC. | 4 MG | MARKETED | DIN 02529505 |
| AG-PERINDOPRIL ERBUMINE | ANGITA PHARMA INC. | 8 MG | MARKETED | DIN 02529513 |
| APO-PERINDOPRIL | APOTEX INC | 2 MG | MARKETED | DIN 02289261 |
| APO-PERINDOPRIL | APOTEX INC | 4 MG | MARKETED | DIN 02289288 |
| APO-PERINDOPRIL | APOTEX INC | 8 MG | MARKETED | DIN 02289296 |
| AURO-PERINDOPRIL | AURO PHARMA INC | 2 MG | MARKETED | DIN 02459817 |
| AURO-PERINDOPRIL | AURO PHARMA INC | 4 MG | MARKETED | DIN 02459825 |
Canadian availability and sourcing
Nexara Health supplies this product to licensed Canadian healthcare buyers. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.